“…Interestingly, this machinery can be used for the heterologous expression of different LanA substrates, with a special focus on lantibiotics, , a class of lanthipeptides characterized by the presence of antimicrobial activity, although also lanthipeptides with antifungal, antiviral, morphogenetic, anticonceptive, or antiallodynic functions have been described . Moreover, the lanthipeptide biosynthetic machinery has been used to design new-to-nature lanthipeptides, generating peptides with enhanced activity or stability. , The heterologous expression of lanthipeptides using the nisin biosynthetic machinery has been broadly used for the heterologous expression of newly designed antimicrobials. ,− However, the substrate specificity of the synthetase enzymes NisB and NisC limits the production of this type of variant compounds on a large scale. Therefore, new and promiscuous lanthipeptide synthetase enzymes with enhanced properties to fully process a large number of unrelated LanA substrates or with the ability to introduce rings with different topologies could be used for the effective heterologous production of novel bioactive lanthipeptides, either engineered variants or lanthipeptides from different (exotic) origins.…”